CSIP and its partner organizations sometimes contribute articles about the problems and issues posed by illicit online pharmacies in various media outlets. Various news and information organizations also report on the work of CSIP. This page contains collections of articles written by CSIP staff or partners about the organization, as well as stories about CSIP from the media.
Marjorie Clifton, Executive Director of the Center for Safe Internet Pharmacies (CSIP), recently penned a blog for the Huffington Post in which she highlighted how the recent death of the musical star Prince, seemingly from opioid use, is a stark reminder of the ever-present dangers of the potential for prescription drug abuse. This danger is increasingly a concern, especially among teenagers.
In the blog, Clifton wrote: “Most parents are unaware of both how common prescription medicine abuse has become in high schools across America, and how easy it is for young people to acquire pills in their own homes and classrooms. Prescription medicines are now the most commonly abused drugs among 12 to 13 year olds. And, medications like Adderall, a commonly prescribed ADHD medication, are being sold peer-to-peer in academically competitive settings as a ‘normal’ way for kids to focus and stay awake for long study hours.”
Clifton suggested five important steps parents and other adults can take to help educate about the dangers of prescription drug abuse.
A review article in the February 2016 issue of the Journal of Health Communication: International Perspectives identified 13 organizations working in the area of consumer education on illicit online pharmacies; 9 of which were engaged in a health promotion activity. CSIP was included in the study – with emphasis placed on its social media efforts to raise awareness of the importance of purchasing medications from safe online sources.
In a recent blog article for the website CircleID, which deals with issues related to internet infrastructure, Libby Baney, Executive Director of the Alliance for Safe Online Pharmacies (ASOP), highlighted the important role internet registries and registrars have in addressing the illegal activities of fraudulent online pharmacies. The article gave tribute to significant efforts on the part of these entities to hold website address registrants responsible if those addresses are being used to support illicit online activities, including the production and distribution of fake medicines.
In particular, Baney noted a recent Sanofi survey, highlighted by CSIP, which reported that 81% of Americans are concerned by illegal online drug sellers and the threat of counterfeit or dangerous medicines. She also noted efforts among CSIP’s registrar members to address the use of website addresses in their registries for illegal purposes:
“The public health threat posed by illegitimate online drug sellers is what brought together three major domain competitors — GoDaddy, Rightside and Neustar — in 2010. Joined by ten other major companies, representing different “chokepoints” in the Internet purchasing chain, the group formed the nonprofit Center for Safe Internet Pharmacies (CSIP). In 2014 alone, CSIP members report taking action on 9.6 million illegitimate pharmacy websites.”